Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Haishosan-kyokuto is a Japanese Kampo (herbal) medicine manufactured by Kyokuto Pharmaceutical Industrial. It is based on the traditional Haishosan formula, which is indicated for the treatment of purulent skin diseases and inflammatory conditions characterized by suppuration, such as abscesses and boils. The formulation typically consists of three botanical ingredients: Platycodon root (Kikyō), Paeonia root (Shaku-yaku), and Immature Orange (Kijitsu). In the context of dental medicine, it is being investigated as an adjunctive treatment to amoxicillin for managing acute exacerbations of periodontitis and periodontal abscesses, aiming to improve wound healing and reduce local inflammation by promoting the drainage of pus and modulating inflammatory signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on haishosan-kyokuto.